Nasal Spotlight: Advances in Systemic and Nose-to-Brain Delivery
Friday • May 8, 2025 • 10:30–12:00 Noon
Moderator: Julie Suman, Ph.D., Aptar Pharma, Congers, USA
A Physiologically-based Pharmacokinetic Model to Predict Nose-to-Brain Drug Delivery
Will Ganley
Nanopharm, an Aptar Pharma Company
Nanopharm, an Aptar Pharma Company
Next Generation Soft Mist Nasal Sprays for Intranasal Delivery of CNS Therapies
Nicolas Buchmann
Resyca
Resyca
Discover More
Fast Tracking Complex Delivery Systems: From Targeted Nasal Delivery to High Dose Lung Delivery
Adrian Raiche and Keith Ung
Kindeva
Kindeva
Emerging Role of Nasal Casts and Automation for the In Vitro Evaluation of Nasal Drug Products
Grant Thurston and Ben Okorodudu
Proveris Scientific Corporation
Proveris Scientific Corporation
Meta Analysis of Variables Affecting Nasal Spray Product Actuation Force Profile
Goncalo Farias
Aptar Pharma
Aptar Pharma
Impact of Anatomical Variability on Nasal Deposition in Pediatric Subjects of the Same Age and Gender
Navid Monshi Tousi and Hosein Sadafi
FLUIDDA
FLUIDDA
Characterization Study of Nasal Deposition Targeting the Central Nervous System
Claudia Costa
Hovione
Hovione
Preliminary Development of a Nanostructured Nasal Powder for Nose-to-Brain Delivery of a Neuro-Active Steroid
Anna Vivani
INTO
INTO
Optimizing Intranasal Delivery of Peptides for Targeted Brain Drug Delivery in Transgenic Mouse Models of Alzheimer’s Disease
Chun Yuen Jerry Wong
Macquarie University
Macquarie University
Assessment of the Semi-Automatic Filling of UDS-P Device with Engineered Powders for Nasal Delivery
Reanne Beaird
Nanopharm
Nanopharm
Novel Spray-Dried Nasal Powder of Eletriptan: In Vitro and Pre-Clinical In Vivo Studies
Jonas Sävmarker
Orexo AB
Orexo AB
The Importance of Shear Thinning for High Viscosity Nasal Suspensions
Summer Hancock
Phillips Medisize
Phillips Medisize
Modelling the Impact of Mucoadhesive Formulations on Intranasal Delivery of RIG-101, a Stem-Loop Ribonucleic Acid Therapeutic
Jag Shur
RIGImmune
RIGImmune
Development of a Particle Engineered Aspirin Powder for Intranasal Delivery: Evaluating Delivery Performance from a Novel Intranasal Device
Julie-Ann Penton
Therakind Limited
Therakind Limited
Comparison of Solution and Suspension Nasal Spray Formulations by Laser Diffraction and Next Generation Impactor Methods
Gözde Fidan and Sulenur Ekmekci
World Medicine
World Medicine
CO-ORGANIZERS
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS
